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Abstract— In diagnosis and treatment planning of brain
tumors, characterisation and localization of tissue plays an
important role. Blind source separation techniques are gen-
erally employed to extract the tissue-specific profiles and its
corresponding distribution from the multi-parametric MRI.
A 3-dimensional tensor is constructed from in-vivo multi-
parametric MRI of high grade glioma patients. Constrained
canonical polyadic decomposition (CPD) with common factor in
mode-1 and mode-2 and l1 regularization on mode-3 is applied
on the 3-dimensional multi-parametric tensor to characterize
various tissue types. An initial in-vivo study shows that CPD
has slightly better performance in identifying active tumor and
the tumor core region in high-grade glioma patients compared
to hierarchical non-negative matrix factorization.
I. INTRODUCTION
Accurate characterisation and localization of tissue types
play a key role in brain tumor diagnosis and treatment
planning. Neuro-imaging methods provide anatomical and
pathophysiological information about brain tumors and aid
in diagnosis, treatment planning and follow-up of patients.
Currently, conventional magnetic resonance imaging (cMRI)
is mainly used for detection and analysis of brain tumor upon
suspicion. In recent years, many advanced magnetic reso-
nance (MR) modalities, such as perfusion-weighted imaging
(PWI), diffusion-weighted imaging (DWI) and MR spec-
troscopic imaging (MRSI) are being used for brain tumor
diagnosis [1], [2], [3]. Instead of using the MR modalities
independently, it has been shown that combining several
MRI modalities (multi-parametric MRI) improves diagnostic
accuracy when it comes to grading gliomas [4], [5]. The
tumor region of glioblastoma multiforme (GBM) could con-
sist of several tissue types, which represent actively growing
tumor, necrosis or normal brain tissue [1]. Hierarchical non-
negative matrix factorization (hNMF) has been applied to
brain MRSI data to differentiate various tissue patterns in
GBM patients [1]. Recently, a variation of hierarchical non-
negative matrix factorization (hNMF) algorithm was applied
to multi-parametric MRI (MP-MRI) data for tumor tissue
segmentation [5].
Tensorizing the matrix and using suitable tensor decom-
positions has certain advantages in blind source separation
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problems [6]. In [7] non-negative canonical polyadic decom-
position has been used for tissue differentiation from MRSI
data. In this paper, a tensor based algorithm is proposed for
tissue type differentiation in high-grade glioma patients from
MP-MRI. A modified version of the tensor approach in [7]
has been applied to MP-MRI imaging. The proposed method
consists of representing the MP-MRI data in a 3-dimensional
tensor and applying constrained canonical polyadic decom-
position (CPD) with l1 regularization to the MP-MRI tensor.
The performance of the CPD algorithm was evaluated using
expert segmentation and compared with hierarchical non-
negative matrix factorization (hNMF) [5].
II. MATERIALS
A. Data acquisition
All the MP-MRI acquisition was performed on a 3T MR
system (Philips Achieva, The Netherlands) at the University
Hospital of Leuven (UZ Leuven), using a body coil for
transmission and an 8-channel head coil for signal reception.
The total scanning time for all MRI modalities was around
45 min. 14 high-grade glioma patients (11 grade IV, 2 grade
III and one grade II astrocytoma with focal progression to
a grade III glioma) were scanned for this study. The lesions
were classified according to grade using the 2007 WHO
classification [8], with histopathological confirmation in all
cases. The study involving human subjects has been approved
by the human ethics review board of the institute. Written
informed consent was obtained from every patient before
participation.
B. Conventional magnetic resonance imaging (cMRI)
An axial spin echo T2-weighted MRI was acquired with
the following parameters: repetition time (TR)/ echo time
(TE): 3000/80 ms; slice/gap: 4/1 mm; turbo factor: 10;
field of view [FOV]: 230×184 mm2; acquisition matrix:
400×300.
A T1-weighted 3-D spoiled gradient echo MRI scan
with contrast administration was performed with the follow-
ing parameters: fast field echo, TR/TE/inversion time (TI):
9.7/4.6/900 ms; flip angle: 8◦; turbo field echo factor: 180;
acquisition voxel size: 0.98×0.98×1 mm3; 118 contiguous
partitions.
An axial FLAIR MRI scan was acquired with the follow-
ing parameters: TR/TE/TI: 11000/120/2800 ms, slice/gap:
4/1 mm, FOV: 230×184 mm2, acquisition matrix: 240×134.
C. Perfusion weighted imaging (PWI)
Perfusion images were obtained using Dynamic
Susceptibility-weighted Contrast-enhanced (DSC) MRI
with a gradient-echo EPI sequence: TR/TE: 1350/30 ms;
slice/gap: 3/0 mm; dynamic scans: 60; FOV: 200×200
mm2; matrix: 112×109; scan time: around 1min26s. EPI
data were acquired during the first pass following a rapid
injection of a 0.1mmol/kg body weight bolus of meglumine
gadoterate (Dotarem, Guerbet, France) via a mechanical
pump at a rate of 4mL/s, followed by a 20-mL bolus of
saline.
DSC data were analyzed using the DSCoMAN plugin [9]
in ImageJ [10]. Relative cerebral blood volume (rCBV) maps
were derived from the dynamic signal intensity curves using
the method proposed by Boxerman et al. [11].
D. Magnetic resonance spectroscopic imaging (MRSI)
A 2D-1H MRSI protocol was used as previously described
in [12]. A point-resolved spectroscopy sequence was used
as the volume selection technique with a bandwidth of
1.3kHz for the conventional slice-selective pulses; TR/TE:
2000/35ms; FOV: 160×160mm2; maximal volume of interest
(VOI): 80×80mm2; slice thickness: 10mm; acquisition voxel
size: 10×10mm2; reconstruction voxel size: 5×5mm2; re-
ceiver bandwidth: 2000Hz; samples: 2048; number of signal
averages: 1; water suppression method: multiple optimiza-
tions insensitive suppression train [13]; first- and second-
order pencil beam shimming; parallel imaging: sensitivity
encoding with reduction factors of 2 (left-right) and 1.8
(anterior-posterior); scan time: 3min30s.
The raw MRSI data were exported from the Philips
platform after standard post-processing (zero-filling in k-
space, transformation from k-space to spatial domain, auto-
matic phase correction and eddy current correction). Further
processing was done with MatLab 2012b (MathWorks, Mas-
sachussets, USA) based SPID software [14]. AQSES-MRSI
[15] was used to quantify the following metabolites using an
experimentally acquired metabolite basis set: Lip at 1.3ppm,
Lac, NAA, Glx, Cre, Cho, mI and Gly. The residual water
was removed using MPFIR (Maximum-Phase Finite Impulse
Response) filtering [16], a model order 25 and the spectral
range from 0.25 to 4.2ppm was used. A band of voxels at
the outer edges of the VOI was omitted to avoid chemical
shift displacement artifacts and lipid contamination.
E. Diffusion kurtosis imaging (DKI)
An EPI DWI sequence with a spin-echo readout was used
to acquire the DKI data, according to an optimized DKI
protocol [17]. Implemented b-values were 0, 700, 1000,
and 2800s/mm2, applied in respectively 10, 25, 40, and
75 uniformly distributed directions. The following param-
eters were used throughout the DKI acquisition sequence:
TR/TE: 3200/90 ms; gradient duration/diffusion time in-
terval: 20/48.3 ms; FOV: 240×240 mm2; matrix: 96×96;
number of signal averages: 1; slice/gap: 2.5/0 mm; parallel
imaging: SENSE with factor 2 in the antero-posterior direc-
tion. The scan time was 17min30s.
After motion and eddy current correction [18],
isotropic smoothing was applied using a Gaussian kernel
(FWHM=3mm) to reduce Gibbs ringing. However,
smoothing was applied to the b=0 and b=700 images only,
so as not to alter the nature of the noise distribution in the
highly diffusion-weighted images in order to avoid a noise
bias in the subsequent tensor estimation [19]. Diffusion
and kurtosis tensors were estimated in each voxel using a
constrained weighted linear least-squares algorithm [19].
Mean diffusivity (MD), fractional anisotropy (FA) and
mean kurtosis (MK) maps were derived from the tensors
according to [17], [20].
F. Data co-registration
All the MP-MRI modalities were co-registered and
brought to the same spatial resolution to perform voxel-wise
analysis. Cubic spline interpolation was used to create an
interpolated set of T1+C images, with one slice coinciding
with the central plane of the MRSI volume of interest.
Only the MRI data that are within the MRSI region of
interest (ROI) were considered for analysis. Skull-stripping
was applied to all images prior to co-registration. The cMRI
datasets and the PWI dataset were rigidly co-registered to
the interpolated T1+C reference set using SPM [21]. The
normalized mutual information criterion was used for co-
registration [22], with cubic spline interpolation for reslicing.
Diffusion-weighted parameter maps were non-linearly co-
registered to the T2-weighted MRI (co-registered with T1+C)
using ExploreDTI [23] to minimize the local misalignment
between the EPI distorted DKI data and the cMRI data.
The MRSI data were spatially aligned with the reference
set and resampled using cubic spline interpolation. All MRI
parameters were brought to the spatial resolution of the
original T1+C dataset, i.e. 0.98×0.98×1 mm3. Only the
voxels that are within the MRSI ROI are considered for
analysis.
III. METHOD
A. Tensor construction
For each voxel in the ROI, a vector X is constructed
consisting of MP-MRI features as shown in Fig. 1a. The
vector X consists of:
1) 7 metabolite concentrations mI, Gly, Cho, Cre, Glx,
NAA, Lac and Lip from the MRSI modality.
2) T2, T1+C and FLAIR from the cMRI modality.
3) rCBV values from the PWI modality.
4) MD, MK and FA values from the DKI modality.
5) Smoothed version of T2, T1+C, FLAIR, rCBV, MD,
MK and FA features using a moving average window
with kernel size 3×3.
6) Smoothed version T2, T1+C, FLAIR, rCBV, MD, MK
and FA features using a moving average window with
kernel size 5×5.
A 3-way MP-MRI tensor T is constructed by stacking XXT
from all the voxels in the MP-MRI grid as shown in Fig. 1b.
Fig. 1: (a) Construction of feature vector X from MP-MRI.
(b) Construction of the MP-MRI tensor T from the feature
vector X . K is the total number of voxels in the region of
interest (ROI).
B. Constrained canonical polyadic decomposition
Canonical polyadic decomposition (CPD) is a tensor de-
composition method, where the tensor is decomposed into a
sum of rank-one tensors [24]. CPD of a third-order tensor
X ∈ RI×J×K can be written as
X ≈ JABCK≡ R∑
r=1
ar ◦br ◦ cr, (1)
where A = [a1,a2, ...,aR] ∈ RI×R, B = [b1,b2, ...,bR] ∈ RJ×R
and C = [c1,c2, ...,cR] ∈ RK×R are factor matrices. R is the
rank, defined as the number of rank-one terms. ’◦’ represents
outer product.
In the MP-MRI tensor T , the frontal slices are symmet-
rical, therefore we constrain the frontal slices of each CPD
rank-one term to be symmetric. To maintain symmetry, a
common factor matrix is used for mode-1 and mode-2 in the
CPD as shown in Fig. 2. Tissue abundances are kept positive
by imposing a non-negative constraint on the mode-3 factor
matrix in the CPD.
Fig. 2: Partial non-negative CPD of MP-MRI tensor T : MP-
MRI tensor T is decomposed into R rank-1 tensors. Common
factor S is used in mode-1 and mode-2 to maintain symmetry
of frontal slices. Each si gives a tissue-specific feature vector
and the corresponding hi gives the spatial distribution of
the respective tissue type, upon reshaping. A non-negativity
constraint is imposed only on H in the decomposition.
Each rank-one term obtained from the constrained CPD
of the MP-MRI tensor T is expected to correspond to a
particular tissue type. Therefore, the mode-3 factor matrix, H
will be sparse, meaning that each row will mostly have only
one high value. l1 regularization is applied on the mode-3
factor matrix H in the partial non-negative CPD to exploit
the sparsity assumption of the tissue type distribution.
[S∗,H∗] = argminS,H≥0 ‖T −
R
∑
i=1
S(:, i)◦S(:, i)◦H(:, i)‖22+λ‖Vec(H)‖1,
(2)
where S represents a matrix with tissue-specific feature vec-
tors as columns, H is a matrix containing their corresponding
distribution vectors and λ is the parameter which controls
the sparsity. The tensor decomposition was performed using
Tensorlab Matlab package [25]. Common mode-1 and mode-
2 factor, non-negativity of H (mode-3) and l1 regularization
are applied using structured data fusion method [26] in
Tensorlab.
C. Validation
Dice score: For each patient, the tissue segmentation were
obtained from their corresponding abundance values, H.
The tissue segmentation was performed by assigning each
voxel to a particular source using k-means clustering on the
abundance values, H. Number of classes is set equal to R,
the number of sources obtained from CPD. The segmentation
obtained from CPD was compared to the manual segmenta-
tion by a radiologist (SVC, with 6 years of experience in
brain tumor research) using the dice score:
Dicetissue = 2× Atissue,CPD∩Atissue,expertAtissue,CPD+Atissue,expert
where, Dicetissue is the dice score, Atissue,CPD is the area of
tissue segmentation obtained from the CPD algorithm and
Atissue,expert is the tissue area labelled by a radiologist.
Source correlation: In this method Pearson’s linear corre-
lation coefficient is calculated between the estimated feature
vectors and the tissue-specific feature vectors based on expert
labelling of the in-vivo MP-MRI voxels [1]. The expert label
based feature vector for a particular tissue type is computed
as the average of all the feature vectors from the voxels which
are labelled by the expert as belonging to that tissue type.
IV. EXPERIMENTAL RESULTS
The feasibility of constrained CPD algorithm in differ-
entiating tissue types is tested by applying it on 14 MP-
MRI datasets from patients with high-grade glioma. The
performance of the constrained CPD algorithm is compared
with the hNMF algorithm [5]. Table I shows the dice score
for active tumor and the tumor core region and source
correlation for the active tumor tissue type as computed
by the constrained CPD and the hNMF algorithm. Table
I also shows the mean and standard deviation of the dice
score and source correlation over 14 MP-MRI datasets. The
constrained CPD algorithm has slightly better mean values
for the dice score, however the increase was not significant.
The mean source correlation value is clearly better using
CPD compared to hNMF. For all the patients, the rank R is
selected manually for both constrained CPD and hNMF.
The result of applying the constrained CPD algorithm on
one of the MP-MRI datasets from a grade IV patient is
TABLE I: Dice scores and source correlation of 14 HGG
patients using CPD and hNMF algorithms. Dice scores are
shown for active tumor and the tumor core (tumor + necrosis)
region. Source correlation is shown for active tumor tissue
type. Mean and standard deviation are shown in the last two
rows, respectively.
CPD-l1 hNMF
Dice Dice Tumor source Dice Dice Tumor source
tumor core correlation tumor core correlation
PT01 0.83 0.96 0.94 0.81 0.98 0.50
PT02 0.77 0.85 0.95 0.78 0.86 0.92
PT03 0.90 0.95 0.97 0.81 0.92 0.51
PT04 0.81 0.88 0.95 0.74 0.82 0.88
PT05 0.89 0.89 0.98 0.71 0.71 0.78
PT06 0.88 0.95 0.99 0.82 0.94 0.62
PT07 0.76 0.88 0.80 0.74 0.90 0.54
PT08 0.81 0.94 0.91 0.75 0.86 0.93
PT09 0.69 0.83 0.93 0.76 0.90 0.98
PT10 0.79 0.59 0.95 0.54 0.50 0.74
PT11 0.87 0.87 0.98 0.88 0.88 0.96
PT12 0.76 0.76 0.98 0.75 0.75 0.98
PT13 0.92 0.92 0.98 0.93 0.93 1.00
PT14 0.88 0.88 0.99 0.89 0.89 0.98
Mean 0.83 0.87 0.95 0.78 0.85 0.81
std 0.07 0.10 0.05 0.09 0.13 0.19
shown in Fig 3 and 4. Fig 3 shows some of the relevant
input MRI features (first two rows) and the abundance
maps obtained from hNMF and CPD algorithms. For hNMF
only four out of six relevant abundance maps are shown,
whereas in case of CPD a decomposition of rank R= 4 was
performed and all abundance maps are shown. The sources
which represent tissue-specific MP-MRI features obtained
from CPD and hNMF algorithms are shown in Fig. 4a. The
segmented region of active tumor and necrosis obtained from
the CPD and hNMF algorithms is shown in Fig. 4b along
with the radiologist segmentation. From Fig 3 and 4 we can
observe that for this patient (PT03 in Table I) the CPD based
algorithm provides a better active tumor segmentation than
hNMF based algorithm (Dice tumorCPD = 0.90 and Dice
tumorhNMF = 0.81).
V. DISCUSSION AND CONCLUSION
In this paper we have described a method to represent
the MP-MRI data in a 3-D tensor. An algorithm using
constrained canonical polyadic decomposition with l1 reg-
ularization was proposed for tissue type differentiation in
high-grade glioma patients from multi-parametric MRI. To
explore feasibility of the proposed algorithm, it was tested
on 14 MP-MRI datasets from patients having high-grade
glioma. The constrained CPD algorithm performs slightly
better than the existing tissue type differentiation method
based on hNMF, but the improvement in dice score is not
significant. However, the CPD algorithm has clearly better
source correlation than hNMF. Higher source correlation
implies that the estimated source features for a particular
tissue type better resembles the actual MP-MRI features
observed in the region corresponding to that tissue type. This
helps in identifying the tissue type from the sources. The
main advantage of the tensor approach is that we need to
Fig. 3: Coregistered MRI maps of several modalities and
tissue abundance maps obtained from hNMF and CPD
algorithms. The input maps: (A) T2, (B) T1+C, (C) MD, (D)
MK, (E) rCBV, (F) Cho, (G) Cre and (H) Lip. The green box
indicates the ROI. (I-L) tissue abundance maps obtained from
hNMF ((I) Active tumor, (J) Necrosis, (K) Edema). (M-P)
tissue abundance maps obtained from constrained CPD ((M)
Active tumor, (N) Necrosis, (O)) Edema).
select only one rank R, whereas in the hNMF algorithm we
need to select two ranks, one for each group in the second
step of hNMF [5]. Therefore, automation of the CPD based
algorithm will be much easier compared to hNMF. Also in
the tensor approach, the tensor construction couples different
MP-MRI features because of the XXT in the frontal slices.
Therefore, in the sources obtained from the CPD algorithm
the features will be coupled, meaning that an individual
feature will not appear as a separate source. This is the
reason for having higher source correlation values in the CPD
algorithm. Moreover, for each voxel, the XXT in the frontal
slices will give more weight to dominant features and least
significant features will be suppressed. In this in-vivo study
we have shown that a tensor formulation can be used for
tumor characterization in multi-parametric MRI and further
research in this direction is promising.
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